Clinical Trials on Urologic Neoplasms in Australia

Total 5852 results

Exelixis

Active, not recruiting

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (COSMIC-313)

Renal Cell Carcinoma

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
Melanoma Institute Australia
Merck Sharp & Dohme LLC

Not yet recruiting

Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma (Neo PeLeMM)

Mucosal Melanoma

Australia
Mesoblast, Ltd.

Completed

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Diabetic Nephropathy | Type 2 Diabetes

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumors

Australia
Professor Michael Bourke

Completed

Non-invasive Risk Stratification of CR AMN/SSP (FIT)

Adenomatous Polyps

Australia
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Australia
Bayside Health
Monash University; Bupa Aged Care Australia

Recruiting

Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities

Respiratory Tract Infections | Urinary Tract Infections | Antimicrobial Stewardship | Skin and Soft Tissue Infections

Australia
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
AceLink Therapeutics, Inc.
Novotech (Australia) Pty Limited

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Autosomal Dominant Polycystic Kidney

Australia
The Hearing Cooperative Research Centre
St Vincent's Hospital Melbourne; Royal Victoria Eye and Ear Hospital; Cochlear; Royal Prince Alfred Hospital, Sydney, Australia and other collaborators

Completed

Cochlear Implant With Anti-Inflammatory Agent

Hearing Loss

Australia
Frequency Therapeutics

Completed

First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

Hearing Loss

Australia
Melbourne Health

Completed

Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan

Renal Failure | Left Ventricular Hypertrophy

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (Neo ReNi II)

Stage II Melanoma

Australia
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Ambrx, Inc.

Completed

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Breast Neoplasms | Solid Tumors | Gastric Neoplasm

United States, Australia
The Hearing Cooperative Research Centre
Royal Victoria Eye and Ear Hospital; Cochlear

Completed

Clinical Metrics for Assessing Cochlear Implant Recipient MAPs

Hearing Loss

Australia
The Hearing Cooperative Research Centre
Royal Victoria Eye and Ear Hospital; Cochlear

Completed

Cochlear Implant Low Power Strategy

Hearing Loss

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Fermiscan Ltd

Unknown

Use of Hair to Diagnose Breast Cancer

Breast Cancer

Australia
Bristol-Myers Squibb

Completed

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

Neoplasms | Solid Tumors | Metastases

Australia
Western Sydney Local Health District

Completed

Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study (SERRESH)

Sessile Serrated Adenoma

Australia
Fermiscan Ltd

Unknown

Use of Hair to Diagnose the Presence of Breast Cancer

Breast Cancer

Australia
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) (KEYNOTE-B61)

Renal Cell Carcinoma

Poland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
Peter MacCallum Cancer Centre, Australia

Recruiting

Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma Refractory

Australia
Murdoch Childrens Research Institute

Recruiting

Methylphenidate in Childhood Apraxia of Speech

Childhood Apraxia of Speech

Australia
The University of Queensland
University of California, San Diego; University of Sydney

Completed

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample)

Pain, Chronic | Pain, Intractable

Australia
Sonova AG
Sonova Audiological Care Australia Pty Ltd

Completed

Evaluation of Software for Self-Fitting of Hearing Aids by People With Hearing Loss

Hearing Loss

Australia
The Hearing Cooperative Research Centre
Cochlear; Attune Hearing; Sydney Cochlear Implant Clinic

Completed

Outcome Prediction in Cochlear Implant Recipients

Hearing Loss

Australia
Impel Pharmaceuticals

Completed

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 (SNAP101)

Acute Agitation

Australia
Arbele Pty Ltd

Recruiting

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Gastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal Junction

Hong Kong, Australia
Royal North Shore Hospital
University of Sydney; Varian Medical Systems

Active, not recruiting

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking (LIGHTSABR)

Neoplasms | Lung Neoplasms

Australia
Royal North Shore Hospital

Withdrawn

Multi-target Tracking in Prostate Radiotherapy Using MLC and KIM (KOALA)

Prostate Cancer

Australia
Royal North Shore Hospital

Completed

Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (BOOSTER)

Prostate Cancer

Australia
St George Hospital, Australia

Recruiting

Hemiablative Focal Brachytherapy Pilot Study

Prostate Cancer

Australia
Royal North Shore Hospital
University of Sydney

Completed

Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy. (CALYPSO)

Prostate Cancer

Australia
St Vincent's Hospital, Sydney

Recruiting

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer (4CAST)

Triple Negative Breast Cancer

Australia
Bayside Health

Completed

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Non-Hodgkin's Lymphoma (CD20+)

Australia
Royal North Shore Hospital

Active, not recruiting

Liver Function Investigation With SPECT (LiverINSPECT)

Liver Cancer, Adult

Australia
Genzyme, a Sanofi Company

Completed

Phase I FOLFOX Combination

Advanced Colorectal Carcinoma

Australia
Surgical Outcomes Research Centre (SOuRCe)

Recruiting

PRIORITY-CONNECT 2 Pilot Trial

Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Oesophageal Cancer

Australia
Jagiellonian University
Medical University Innsbruck; University Medical Centre Ljubljana; University... and other collaborators

Completed

Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms (TECANT)

Neuroendocrine Tumors

Austria, Poland, Slovenia
Hoffmann-La Roche

Completed

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) (IMmotion151)

Renal Cell Carcinoma

Korea, Republic of, United States, France, Italy, United Kingdom, Canada, Australia, Brazil, Denmark, Spain, Turkey, Japan, Czechia, Singapore, Thailand, Taiwan, Russian Federation, Germany, Bosnia and Herzegovina, Poland, Mexico
Hoffmann-La Roche

Completed

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Urinary Tract Cancer

Hungary, Italy, Australia, Czechia, United Kingdom, Austria, Belgium, Brazil, Bulgaria, Croatia, Denmark, Estonia, Greece, Portugal, Spain, Canada, India, Romania, Switzerland, Poland, Ireland, Colombia, Germany, Argentina, China, Lebanon, ... and more
Medtronic Cardiac Rhythm and Heart Failure

Completed

Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System

Syncope | Recurrent Symptomatic Atrial Fibrillation

Netherlands, Australia, United Kingdom, Belgium, Austria, Russian Federation, Slovakia
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Evopoint Biosciences Inc.

Completed

Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Australia

Clinical Trials on Urologic Neoplasms in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations